TrialAnnals of oncology : official journal of the European Society for Medical Oncology2011

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.

R Stupp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.